Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Inger
Inger Andersson, Storvreta SE
| Patent application number | Description | Published |
|---|---|---|
| 20100099163 | SEPARATION MATRIX FOR VIRAL PURIFICATION - The present invention relates to a method of preparing a separation matrix comprising at least one insoluble carrier to which sulphate ligands have been attached via extenders, which method comprises coupling, in a first step, of the sulphate ligands to the extenders and, in a subsequent step, attaching the extenders to an insoluble carrier. The invention also relates to a separation matrix comprised of at least one insoluble carrier to which sulphate ligands have been attached via extenders. Advantageously, no sulphate ligands are directly attached to the insoluble carrier. The extenders may be natural polymers, such as dextran, and the insoluble carrier may be made from natural polymers, such as agarose, or synthetic polymers. The invention also relates to a method of purifying virus, such as influenza virus, using a separation matrix according to the invention. | 04-22-2010 |
Inger Bjorck, Lund SE
| Patent application number | Description | Published |
|---|---|---|
| 20100280132 | METHOD FOR MODIFYING POLYPHENOL CONTAINING PLANT MATERIALS AND MEDICAL USES OF MODIFIED POLYPHENOL PLANT CONTAINING MATERIALS - The present invention relates to a method for modifying polyphenol containing plant material(s), wherein said method comprises: mixing at least one polyphenol containing material and at least one solvent to provide a mixture; heating the mixture to eliminate bacterial species present to provide a heated mixture; adding at least one polyphenol modifying strain of lactic acid bacteria and optionally at least one protein source, in optional order or simultaneously, to the heated mixture to provide a fermentation mixture; and subjecting the fermentation mixture to conditions suitable for fermentation of the fermentation mixture to provide a mixture of modified polyphenol containing plant material(s); and optionally eliminating the polyphenol modifying strain of lactic acid bacteria to provide a mixture of modified polyphenol containing plant material(s) free from living lactic acid bacteria. | 11-04-2010 |
Inger Byrjalsen, Hiersholm DK
| Patent application number | Description | Published |
|---|---|---|
| 20110256639 | ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS - A method of immunoassay for fragments of a protein such as type II collagen in a biological sample detects fragments having a first epitope containing an isomerised amino acid residue and a second epitope generated by cleavage of the protein by the use of respective antibodies binding each of the two epitopes. | 10-20-2011 |
Inger Byrjalsen, Hoersholm DK
| Patent application number | Description | Published |
|---|---|---|
| 20110244482 | ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II - A method of assay to determine the extent of collagen type II resorption activity comprising measuring the level of fragments of collagen type II that contain a cathepsin K generated neo-epitope not shared by collagen type I by binding the neo-epitope with an antibody specific for the neo-epitope and detecting the level of binding of said binding partner. | 10-06-2011 |
| 20110244483 | ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS - A method of assay measuring in a biological sample fragments of a protein that contain an N-terminal neo-epitope and a C-terminal neo-epitope, each generated by protease cleavage of said protein, comprises binding the N-terminal neo-epitope with a first specific antibody and binding the C-terminal neo-epitope with a second specific antibody, and detecting the extent of dual binding of said antibodies. | 10-06-2011 |
Inger Grunden, Lysekil SE
| Patent application number | Description | Published |
|---|---|---|
| 20100313532 | FILTER - A filter to be used in the expiratory branch of a ventilator, includes a housing arranged with an inlet passage and an outlet passage, a main filter element, a pre-filter member arranged before the main filter element as seen in the flow direction and an air permeable, material capable of collecting medicament droplets in the air stream through the main filter element. | 12-16-2010 |
Inger Kers, Sodertalje SE
| Patent application number | Description | Published |
|---|---|---|
| 20090291983 | 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents - Compounds of formula I | 11-26-2009 |
| 20100137322 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN - The present invention relates to new compounds of formula (I) and to pharmaceutical composition containing said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. | 06-03-2010 |
| 20100286202 | New Compounds - The present invention relates to new compounds | 11-11-2010 |
Inger Lautrup-Larsen, Virum DK
| Patent application number | Description | Published |
|---|---|---|
| 20100009898 | PROTEASE RESISTANT INSULIN ANALOGUES - The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided. | 01-14-2010 |
| 20110092419 | PROTEASE-STABILIZED INSULIN ANALOGUES - The present invention relates to novel insulin analogues comprising mutations at position A14 in the A chain and at positions B27, B28, B29 and B30 in the B chain and exhibiting resistance towards protease; a method for the preparation of such insulin analogues; insulin preparations containing the insulin analogues of the invention; and, a method of treating diabetes mellitus using these insulin analogues. | 04-21-2011 |
Inger Mattsby-Baltzer, Goteborg SE
| Patent application number | Description | Published |
|---|---|---|
| 20080299180 | Peptides based on the sequence of human lactoferrin and their use - The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides. | 12-04-2008 |
| 20080311595 | Rapid fungal detection assay and product - The present invention relates to the use of an assay and product for rapid detection of fungi in a variety of samples suspected of containing fungi, particularly swab samples from the human vaginal area, but also in other environments such as in food and feeds. The product of the invention is suitable for use in a variety of different environments, including in clinical settings, at the point of care, and by patients themselves (bedside kit). | 12-18-2008 |
| 20090186823 | Synthetic arginine substituted peptides and their use - The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars. | 07-23-2009 |
| 20090305313 | Diagnosis of candidiasis and candidemia or invasive candida infection - The use of an antibody to a | 12-10-2009 |
| 20110053833 | SYNTHETIC PEPTIDES AND THEIR USE - At least one embodiment of the present invention relates to new peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars. | 03-03-2011 |
| 20110224152 | SYNTHETIC ARGININE SUBSTITUTED PEPTIDES AND THEIR USE - The present invention relates to new arginine substituted peptides designed based on the sequence of human lactoferrin and to use thereof, in particular for treatment and/or prevention of infections, inflammations, tumours, pain, wounds and/or scars. | 09-15-2011 |